News

UNC School of Medicine Researchers Awarded $5 million for COVID-19 Testing

UNC School of Medicine Researchers Awarded $5 million for COVID-19 Testing

Lauren Brinkley-Rubinstein, PhD, will lead this two-year National Institutes of Health project for COVID-19 testing and prevention in correctional facilities, as part of the NIH Rapidly Accelerating Diagnostics Program.

UNC School of Medicine Researchers Awarded $5 million for COVID-19 Testing - Read More…

Duke Clinical Research Institute, UNC Center for Health Equity Research, and Partners Receive $80-Million NIH Grant to Expand COVID-19 Testing

Duke Clinical Research Institute, UNC Center for Health Equity Research, and Partners Receive $80-Million NIH Grant to Expand COVID-19 Testing

This nationwide program aims to build innovative and sustainable solutions to expand test access and uptake in underserved and vulnerable communities. The UNC School of Medicine lead is Giselle Corbie-Smith, MD, MSc, who is part of the leadership team for the Rapid Acceleration of Diagnostics Program.

Duke Clinical Research Institute, UNC Center for Health Equity Research, and Partners Receive $80-Million NIH Grant to Expand COVID-19 Testing - Read More…

UNC Participates in First Nationwide Network to Study Rare Forms of Diabetes

UNC Participates in First Nationwide Network to Study Rare Forms of Diabetes

John Buse, MD, PhD, will lead the UNC-Chapel Hill site for a collaborative NIH research effort to discover new forms of diabetes, understand their differences, and identify their causes.

UNC Participates in First Nationwide Network to Study Rare Forms of Diabetes - Read More…

UNC Health, School of Medicine Determine Asymptomatic COVID-19 Spread

UNC Health, School of Medicine Determine Asymptomatic COVID-19 Spread

Researchers at the UNC School of Medicine collaborated with UNC Health and found that 0.8 percent of patients who came to a UNC Health facility for non-COVID-19 related reasons during the NC stay-at-home mandate tested positive for the novel coronavirus.

UNC Health, School of Medicine Determine Asymptomatic COVID-19 Spread - Read More…

‘Made in NC’ Initiative Unites Public and Private Sector to Deliver Vital COVID-19 PPE to Health Care Workers Statewide

A new collaboration will produce nearly 2 million N95 respirators per year to address the urgent need for affordable access to essential PPE in communities that need them most.

‘Made in NC’ Initiative Unites Public and Private Sector to Deliver Vital COVID-19 PPE to Health Care Workers Statewide - Read More…

New Vulnerability Found in Lung Squamous cancer may acilitate Drug Targeting at Cellular Level

New Vulnerability Found in Lung Squamous cancer may acilitate Drug Targeting at Cellular Level

New research by scientists at UNC Lineberger Comprehensive Cancer Center and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer. The UNC work was led by Chad Pecot, MD and Emily Harrison, PhD.

New Vulnerability Found in Lung Squamous cancer may acilitate Drug Targeting at Cellular Level - Read More…

Black women with breast cancer experience delayed, longer treatment than whites, study finds

Black women with breast cancer experience delayed, longer treatment than whites, study finds

One in seven black women with breast cancer had delays in starting treatment, and black women also had extended duration of treatment, according to a study led by UNC Lineberger Comprehensive Cancer Center researchers Melissa Troester, PhD, and Marc Emerson, PhD.

Black women with breast cancer experience delayed, longer treatment than whites, study finds - Read More…

Lack of Key Neuropeptide Induces Neuroinflammation to Impair Neural Stem Cells and Limit New Neuron Production

Lack of Key Neuropeptide Induces Neuroinflammation to Impair Neural Stem Cells and Limit New Neuron Production

Published in Neuron, research from the UNC School of Medicine lab of Juan Song, PhD, determined the cell-signaling role of a neuropeptide called cholecystokinin, which is important in regulating neural stem cells and creating adult-born neurons within the hippocampus of the brain.

Lack of Key Neuropeptide Induces Neuroinflammation to Impair Neural Stem Cells and Limit New Neuron Production - Read More…

A Scientific First: How Psychedelics Bind to Key Brain Cell Receptor

A Scientific First: How Psychedelics Bind to Key Brain Cell Receptor

This work, published in Cell and led by the UNC-Chapel Hill lab of Bryan L. Roth, MD, PhD, sets the stage for the discovery of new kinds of antidepressants, anti-anxiety drugs, and treatments for substance use disorders.

A Scientific First: How Psychedelics Bind to Key Brain Cell Receptor - Read More…

Ramsden, Gupta awarded 5-year, $8.8 million grant to study enzyme with important implications for breast and ovarian cancers

Ramsden, Gupta awarded 5-year, $8.8 million grant to study enzyme with important implications for breast and ovarian cancers

The National Cancer Institute has awarded a team led by UNC Lineberger’s Dale Ramsden, PhD, professor in the UNC School of Medicine Department of Biochemistry and Biophysics, a five-year, $8.8 million program project grant to study an enzyme called DNA polymerase theta.

Ramsden, Gupta awarded 5-year, $8.8 million grant to study enzyme with important implications for breast and ovarian cancers - Read More…

Researchers Reveal Safeguarding of a Key DNA Sensor in the Innate Immune System

Researchers Reveal Safeguarding of a Key DNA Sensor in the Innate Immune System

Led by Qi Zhang, PhD, and Robert McGinty, MD, PhD, UNC-Chapel Hill scientists used cryo-electron microscopy technology to produce the first-ever high-resolution structure of the protein cGAS bound to the DNA packaging unit inside human cell nuclei, revealing how cGAS responds to foreign or damaged DNA, but not the body’s healthy DNA.

Researchers Reveal Safeguarding of a Key DNA Sensor in the Innate Immune System - Read More…

UNC Researchers Publish Striking Images of SARS-CoV-2 Infected Cells

UNC Researchers Publish Striking Images of SARS-CoV-2 Infected Cells

The UNC School of Medicine lab of Camille Ehre, PhD, generated high-powered microscopic images showing startlingly high SARS-CoV-2 viral loads on human respiratory surfaces, ready to spread infection in infected individuals and transmit infection to others.

UNC Researchers Publish Striking Images of SARS-CoV-2 Infected Cells - Read More…

UNC Ramps Up Convalescent Plasma Clinical Trial to Fight COVID-19

UNC Ramps Up Convalescent Plasma Clinical Trial to Fight COVID-19

On the heels of FDA authorization of convalescent plasma as a treatment for COVID-19, researchers at UNC are conducting a clinical trial to determine the safety and efficacy of plasma that includes a higher amount of neutralizing antibodies against SARS-CoV-2.

UNC Ramps Up Convalescent Plasma Clinical Trial to Fight COVID-19 - Read More…

New Emergency Department Transition Unit (EDTU) Opened Sept. 1

New Emergency Department Transition Unit (EDTU) Opened Sept. 1

The 36-bed EDTU, which was previously used for clinic space, was renovated during the past two years to help handle the increasing volume in the very busy Emergency Department

New Emergency Department Transition Unit (EDTU) Opened Sept. 1 - Read More…

Scientists Show How Brain Flexibility Emerges in Infants

Scientists Show How Brain Flexibility Emerges in Infants

Cognitive flexibility, which refers to the brain’s ability to switch between mental processes in response to external stimuli and different task demands, seems to begin developing during the first two years of life, which is much earlier than previously thought. UNC BRIC researchers led by Weili Lin, PhD, used magnetic resonance imaging techniques to show the emergence of a functional flexible brain during early infancy.

Scientists Show How Brain Flexibility Emerges in Infants - Read More…

UNC Researchers Launch Clinical Trial for COVID-19 Treatments

UNC Researchers Launch Clinical Trial for COVID-19 Treatments

This study includes phase 2 and phase 3 elements to expedite the evaluation of treatments for adults with moderate cases of COVID-19, with the goal of preventing severe disease that can lead to hospitalizations. The principal investigator is David Wohl, MD, professor of infectious diseases at the UNC School of Medicine.

UNC Researchers Launch Clinical Trial for COVID-19 Treatments - Read More…

Chatham Hospital Recognized As Honoree In 2020 Carolyn Boone Lewis Equity of Care (EOC) Award

Chatham Hospital Recognized As Honoree In 2020 Carolyn Boone Lewis Equity of Care (EOC) Award

Chatham Hospital is one of three hospitals nationwide to recognized by the American Hospital Association as part of the 2020 Carolyn Boone Lewis Equity of Care (EOC) Award.

Chatham Hospital Recognized As Honoree In 2020 Carolyn Boone Lewis Equity of Care (EOC) Award - Read More…

Share This: